等待开盘 12-17 09:30:00 美东时间
-0.020
-0.05%
U.S. stock futures were mixed this morning, with the Dow futures gaining around...
12-04 21:00
Methanex Corporation announced the appointment of Don Marchand to its Board of Directors, effective December 1, 2025. With nearly four decades of experience in finance and energy infrastructure, Marchand brings extensive expertise in financial leadership and corporate strategy, including his role as Executive Vice President and Chief Financial Officer at TC Energy. He holds a Bachelor of Commerce from the University of Manitoba and is a Chartered...
11-25 22:00
Advanced Micro Devices (AMD) rose 5.76% to $215.51 in the afternoon trade on Monday, snapping a seven-session losing streak. The chipmaker has been under pressure this month even after posting record ...
11-25 02:52
Methanex ( ($TSE:MX) ) has issued an update. Methanex Corporation announced a q...
11-18 20:47
Methanex (MEOH) declares $0.185/share quarterly dividend, in line with previous. Forward yield 2.07% Payable Dec. 31; for shareholders of record Dec. 17; ex-div Dec. 17. See MEOH Dividend Scorecard, Y...
11-18 20:28
<p>VANCOUVER, British Columbia, Nov. 18, 2025 (GLOBE NEWSWIRE) — Methanex Corporation announced a quarterly dividend of US$0.185 per share, payable on December 31, 2025, to holders of record on December 17, 2025. Methanex, based in Vancouver, is the world’s largest methanol supplier. Its shares trade on the Toronto Stock Exchange under "MX" and on the Nasdaq Global Select Market under "MEOH". For more information, visit www.methanex.com.</p>
11-18 12:00
今日重点评级关注:HC Wainwright & Co.:维持Oncolytics Biotech"买入"评级,目标价从5美元升至10美元;HC Wainwright & Co.:维持Barinthus Biotherapeutics"买入"评级,目标价从3美元升至4美元
11-18 15:28
CIBC analyst Hamir Patel maintains Methanex (NASDAQ:MEOH) with a Outperformer and raises the price target from $44 to $47.
11-18 01:00
今日重点评级关注:花旗:维持Caribou Biosciences"买入"评级,目标价从5美元升至8美元;HC Wainwright & Co.:上调MoonLake Immunotherapeutics - Class A Ordinary Shares评级至"买入",目标价30美元
11-04 10:31
今日重点评级关注:康托·菲茨杰拉德:维持Cabaletta Bio"超配"评级,目标价从15美元升至30美元;HC Wainwright & Co.:维持Invivyd"买入"评级,目标价从5美元升至10美元
11-03 20:20